These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1176767)

  • 1. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of RNA as a complement inhibitory component in an extract of Ehrlich ascites tumor cells.
    Renk CM; Hoffmann EM
    J Immunol; 1977 Jul; 119(1):263-70. PubMed ID: 326959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.
    Soter NA; Austen KF; Gigli I
    J Immunol; 1975 Mar; 114(3):928-32. PubMed ID: 1167567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
    Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
    Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on heterologous antilymphocyte and antithymocyte sera. IV. Further evidence for a preferential effect on antigen-sensitive cells.
    Barth RF
    J Immunol; 1969 Oct; 103(4):648-54. PubMed ID: 4310736
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concanavalin A on the classical complement pathway.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
    Schultz DR; Arnold PI
    J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro hemolysis of autologous erythrocytes caused by immune murine spleen cells and spherules of the fungus Coccidioides immitis.
    Danley DL; Pappagianis D; Benjamini E
    J Immunol; 1976 Apr; 116(4):970-5. PubMed ID: 1254972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 19. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium azide inhibition of complement-mediated functions.
    Shaw DR; Shaw MW; Hickman SE; Lamon EW; Griffin FM
    Immunology; 1980 Jan; 39(1):53-6. PubMed ID: 7380463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.